Some have relabeled it as Pentadecapeptide Aringate or PDA (altering the acetate to an arginate) and therefore are prescribing it for subcutaneous administration like that, though the confusion about its standing has led to a vivid oral capsule marketplace for BPC in what seems to generally be a grey space https://lorenzj095wbf5.actoblog.com/profile